Home > Rigel Pharmaceuticals Salary

Rigel Pharmaceuticals Salary

  • 36
  • 23
  • 67
Rigel Pharmaceuticals average salary is $39,759, median salary is $39,759 with a salary range from $35,776 to $43,742.
Rigel Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Rigel Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
35,776
Average
39,759
Median
39,759
High
43,742
Total 2 Rigel Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Business Operations Specialist 43,742-43,742 Pasadena, CA, 91050 2014 Rigel Pharmaceuticals Business Operations Specialist Salaries (1)
Rigel Pharmaceuticals Pasadena, CA Salaries
Market Research Analyst 35,776-35,776 Pasadena, CA, 91050 2014 Rigel Pharmaceuticals Market Research Analyst Salaries (1)
Rigel Pharmaceuticals Pasadena, CA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Rigel Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Rigel Pharmaceuticals Jobs
See more Rigel Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
2995

All Patents

830

Grant Patents

1827

Patents Pending

574

Patents Families

More Recent
Rigel Pharmaceuticals... Information
  • Rigel Pharmaceuticals, Inc
  • Industry: Major Drugs
  • City: South San Francisco, CA
  • Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.Our goal is to move one new product candidate for a significant indication into the clinic each year. We have achieved this goal since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.Rigel¡¯s productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates.We have product development programs in allergy/asthma, rheumatoid arthritis and cancer.Our lead product candidate, R788, completed a Phase I